Processing

Please wait...

Settings

Settings

Goto Application

1. WO2001055162 - NUCLEIC ACIDS, PROTEINS, AND ANTIBODIES

Publication Number WO/2001/055162
Publication Date 02.08.2001
International Application No. PCT/US2001/001305
International Filing Date 17.01.2001
Chapter 2 Demand Filed 24.08.2001
IPC
C07K 14/47 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435from animals; from humans
46from vertebrates
47from mammals
C12Q 1/68 2006.1
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
1Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
68involving nucleic acids
CPC
C07K 14/47
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435from animals; from humans
46from vertebrates
47from mammals
C12Q 1/6883
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS
1Measuring or testing processes involving enzymes, nucleic acids or microorganisms
68involving nucleic acids
6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
6883for diseases caused by alterations of genetic material
Applicants
  • HUMAN GENOME SCIENCES, INC. [US]/[US] (AllExceptUS)
  • ROSEN, Craig, A. [US]/[US] (UsOnly)
  • BARASH, Steven, C. [US]/[US] (UsOnly)
  • RUBEN, Steven, M. [US]/[US] (UsOnly)
Inventors
  • ROSEN, Craig, A.
  • BARASH, Steven, C.
  • RUBEN, Steven, M.
Agents
  • HOOVER, Kenley, K.
Priority Data
60/179,06531.01.2000US
60/180,62804.02.2000US
60/184,66424.02.2000US
60/186,35002.03.2000US
60/189,87416.03.2000US
60/190,07617.03.2000US
60/198,12318.04.2000US
60/205,51519.05.2000US
60/209,46707.06.2000US
60/214,88628.06.2000US
60/215,13530.06.2000US
60/216,64707.07.2000US
60/216,88007.07.2000US
60/217,48711.07.2000US
60/217,49611.07.2000US
60/218,29014.07.2000US
60/220,96326.07.2000US
60/220,96426.07.2000US
60/224,51814.08.2000US
60/224,51914.08.2000US
60/225,21314.08.2000US
60/225,21414.08.2000US
60/225,26614.08.2000US
60/225,26714.08.2000US
60/225,26814.08.2000US
60/225,27014.08.2000US
60/225,44714.08.2000US
60/225,75714.08.2000US
60/225,75814.08.2000US
60/225,75914.08.2000US
60/226,27918.08.2000US
60/226,68122.08.2000US
60/226,86822.08.2000US
60/227,00923.08.2000US
60/227,18222.08.2000US
60/228,92430.08.2000US
60/229,28701.09.2000US
60/229,34301.09.2000US
60/229,34401.09.2000US
60/229,34501.09.2000US
60/229,50905.09.2000US
60/229,51305.09.2000US
60/230,43706.09.2000US
60/230,43806.09.2000US
60/231,24208.09.2000US
60/231,24308.09.2000US
60/231,24408.09.2000US
60/231,41308.09.2000US
60/231,41408.09.2000US
60/231,96812.09.2000US
60/232,08008.09.2000US
60/232,08108.09.2000US
60/232,39714.09.2000US
60/232,39814.09.2000US
60/232,39914.09.2000US
60/232,40014.09.2000US
60/232,40114.09.2000US
60/233,06314.09.2000US
60/233,06414.09.2000US
60/233,06514.09.2000US
60/234,22321.09.2000US
60/234,27421.09.2000US
60/234,99725.09.2000US
60/234,99825.09.2000US
60/235,48426.09.2000US
60/235,83427.09.2000US
60/235,83627.09.2000US
60/236,32729.09.2000US
60/236,36729.09.2000US
60/236,36829.09.2000US
60/236,36929.09.2000US
60/236,37029.09.2000US
60/236,80202.10.2000US
60/237,03702.10.2000US
60/237,03802.10.2000US
60/237,03902.10.2000US
60/237,04002.10.2000US
60/239,93513.10.2000US
60/239,93713.10.2000US
60/240,96020.10.2000US
60/241,22120.10.2000US
60/241,78520.10.2000US
60/241,78620.10.2000US
60/241,78720.10.2000US
60/241,80820.10.2000US
60/241,80920.10.2000US
60/241,82620.10.2000US
60/244,61701.11.2000US
60/246,47408.11.2000US
60/246,47508.11.2000US
60/246,47608.11.2000US
60/246,47708.11.2000US
60/246,47808.11.2000US
60/246,52308.11.2000US
60/246,52408.11.2000US
60/246,52508.11.2000US
60/246,52608.11.2000US
60/246,52708.11.2000US
60/246,52808.11.2000US
60/246,53208.11.2000US
60/246,60908.11.2000US
60/246,61008.11.2000US
60/246,61108.11.2000US
60/246,61308.11.2000US
60/249,20717.11.2000US
60/249,20817.11.2000US
60/249,20917.11.2000US
60/249,21017.11.2000US
60/249,21117.11.2000US
60/249,21217.11.2000US
60/249,21317.11.2000US
60/249,21417.11.2000US
60/249,21517.11.2000US
60/249,21617.11.2000US
60/249,21717.11.2000US
60/249,21817.11.2000US
60/249,24417.11.2000US
60/249,24517.11.2000US
60/249,26417.11.2000US
60/249,26517.11.2000US
60/249,29717.11.2000US
60/249,29917.11.2000US
60/249,30017.11.2000US
60/250,16001.12.2000US
60/250,39101.12.2000US
60/251,03005.12.2000US
60/251,47906.12.2000US
60/251,85608.12.2000US
60/251,86808.12.2000US
60/251,86908.12.2000US
60/251,98805.12.2000US
60/251,98908.12.2000US
60/251,99008.12.2000US
60/254,09711.12.2000US
60/256,71905.12.2000US
60/259,67805.01.2001US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) NUCLEIC ACIDS, PROTEINS, AND ANTIBODIES
(FR) ACIDES NUCLEIQUES, PROTEINES ET ANTICORPS
Abstract
(EN) The present invention relates to novel proteins. More specifically, isolated nucleic acid molecules are provided encoding novel polypeptides. Novel polypeptides and antibodies that bind to these polypeptides are provided. Also provided are vectors, host cells, and recombinant and synthetic methods for producing human polynucleotides and/or polypeptides, and antibodies. The invention further relates to diagnostic and therapeutic methods useful for diagnosing, treating, preventing and/or prognosing disorders related to these novel polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of polynucleotides and polypeptides of the invention. The present invention further relates to methods and/or compositions for inhibiting or enhancing the production and function of the polypeptides of the present invention.
(FR) La présente invention concerne de nouvelles protéines. Plus spécifiquement, l'invention concerne des molécules d'acide nucléique isolées, codant pour de nouveaux polypeptides. Cette invention concerne également : de nouveaux polypeptides et anticorps qui se lient à ces polypeptides ; des vecteurs, des cellules hôtes, et des procédés de recombinaison et de synthèse permettant de produire des polynucléotides et/ou polypeptides humains, et des anticorps ; des procédés diagnostiques et thérapeutiques utiles pour le diagnostic, le traitement, la prévention et/ou la prévision de troubles liés à ces nouveaux polypeptides ; des procédés de criblage permettant d'identifier des agonistes et des antagonistes de polynucléotides et polypeptides de l'invention ; des procédés et/ou des compositions permettant d'inhiber ou d'augmenter la production et la fonctionnalité des polypeptides de la présente invention.
Related patent documents
Latest bibliographic data on file with the International Bureau